<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104221">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01940861</url>
  </required_header>
  <id_info>
    <org_study_id>Co-TBI</org_study_id>
    <secondary_id>2010/824</secondary_id>
    <nct_id>NCT01940861</nct_id>
  </id_info>
  <brief_title>Cerebral Oxymetry in Traumatic Brain Injury</brief_title>
  <official_title>Cerebral Oxymetry in Traumatic Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway: Ministry of Health and Care Services</authority>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vasopressor for current treatment protocols for acute traumatic brain injury can lead to
      vasoconstriction and thus cerebral hypoperfusion that can be detected with cerebral oxymetry
      as a drop in SCO2.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Dosage of vasopressor</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Traumatic brain injury</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        TBI
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute traumatic severe brain injury requiring neuro intensive care.

          -  The patient admitted must be at least 18 years of age and under 60 years.

          -  Intoxication is not an obstacle for inclusion as we believe this will not affect the
             recording in relation to our problem.

        Exclusion Criteria:

          -  Traumatic injury in the frontal lobes corresponding to the area where ScO2 monitored.

          -  Patients in pharmacological studies.

          -  Patients with severe heart / lung / blood vessel diseases.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ove Andreas Hagen, MD</last_name>
      <phone>+4790634748</phone>
      <email>ovahagen@online.no</email>
    </contact>
    <investigator>
      <last_name>Ove A. Hagen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 8, 2013</lastchanged_date>
  <firstreceived_date>September 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
